National Health (Immunisation Program – Designated Vaccines) Amendment Determination (No. 1) 2019 (Cth)

National Health (Immunisation Program – Designated Vaccines) Amendment Determination (No. 1) 2019

I, Masha Somi, delegate of the Minister for Health, make the following Determination.

Dated 3 April 2019                             

Dr Masha Somi

Assistant Secretary
Office of Health Protection
Chief Medical Officer Group
Department of Health

Contents

1  Name........................................................................................................................................ 1

2  Commencement........................................................................................................................ 1

3  Authority.................................................................................................................................. 1

4  Schedules................................................................................................................................. 1

Schedule 1—Amendments  2

National Health (Immunisation Program – Designated Vaccines) Determination 2014 (No.1)      2

1  Name

This instrument is the National Health (Immunisation Program – Designated Vaccines) Amendment Determination (No. 1) 2019.

2  Commencement

This instrument commences on the day after this instrument is registered.

3  Authority

This instrument is made under section 9B of the National Health Act 1953.

4  Schedules

Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.

Schedule 1—Amendments

National Health (Immunisation Program – Designated Vaccines) Determination 2014 (No.1)

1  After subsection 7(7)

Insert:

(7A) For item 207A of Schedule 1, a designated vaccine mentioned in that item may be provided to:

(a)    a person who is at least 65 years; or

(b)    an Aboriginal or Torres Strait Islander person who is at least 6 months; or

(c)    a person who is at least 6 months who:

(i)     has cardiac disease including cyanotic congenital heart disease, coronary artery disease and congestive heart failure; or

(ii)    has a chronic respiratory condition including suppurative lung disease, bronchiectasis, cystic fibrosis, chronic obstructive pulmonary disease, chronic emphysema and severe asthma; or

(iii)   has another chronic illness requiring regular medical follow‑up or hospitalisation in the preceding year, including diabetes mellitus, chronic metabolic diseases, chronic renal failure, haemoglobinopathies and impaired immunity (including drug‑induced immune impairment); or

(iv)   has a chronic neurological condition, including multiple sclerosis, spinal cord injuries, seizure disorders or other neuromuscular disorders; or

(v)    has impaired immunity, including HIV infection; or

(d)    a person who is at least 6 months but less than 11 years and is receiving long‑term aspirin therapy; or

(e)    a woman who is pregnant.

2  Subsection 7(8)

Omit “For items 207A and 207B of Schedule 1, a designated vaccine mentioned in those items”, substitute “For item 207B of Schedule 1, a designated vaccine mentioned in that item”.

3  Part 2 of Schedule 1 (table item 207A, column headed “Vaccine and the circumstances in which vaccine may be provided”)

Omit “subsection 7(8)”, substitute “subsection 7(7A)”.

4  Part 2 of Schedule 1 (table item 207A, column headed “Number and timing of doses”)

Omit “3 years”, substitute “6 months”.